Veterinary Bioscience Institute

Continuing Education Credits

The Veterinary Bioscience Institute (VBI) is an approved continuing education provider American Association of Veterinary State Boards. VBI's courses, webinars and workshops also meet the requirements for Continuing Education Units of ASR, CALAS and AALAS. VBI's training also meets the following standards: ISO9000, cGLP, the 2010 Guide and Council of Europe's Directive 86/609 (ETS 123).

Veterinary Bioscience Institute - Logo
Webinars Workshops Online Courses Onsite Training Resources Video Library Blog

3 Rs Sharing Conference ONDEMAND

3 Rs
 Sharing
 Conference 
III - Paving
 the
 Path
 to
 Regulatory 
Acceptance of
 Alternative
 Methods

Facilitating
 the 
Integration
 of 
Alternative
 Methods 
Into
 the
 Regulatory
 Framework

This conference was hosted 
by
 the
 New 
Jersey 
Association
 for 
Biomedical
 Research in
 partnership 
with 
the
 International
 Consortium
 for 
Quality 
&
 Innovation
 in 
Pharmaceutical
 Development
 (IQ) and
 
with 
the 
joint 
support 
of
 PSBR, 
MSMR,
 NCABR. 

Now you can access this confernece ondemand for one low price of $350 for 12 month access.

You will be able to view all of the following sessions and discussion at your convenience.

  • Stem Cells Applications 
    • Kyle Kolaja, PhD, Vice President Business Development, Cellular Dynamics 
  • New Direction & Transformation of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) 
    • Warren Casey, PhD, DABT, Senior Toxicologist & Acting Director National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) 
  • Panel Discussion: Key Issues and Challenges to the Implementation & Utilization of Alternative Methods
    • Moderator: Michael Kastello, DVM, PhD, Vice President and Global Deputy, Animal Research and Welfare, Sanofi-Aventis US, Chief Veterinary Officer, Sanofi Group 
    • Panelists: 
      • Warren Casey, PhD, DABT, Senior Toxicologist & Acting Director NICEATM Michael Graziano, PhD, DABT, VP Drug Safety Evaluation, Bristol-Myers Squibb 
      • Abigal Jacobs, PhD, Associate Director of Pharmacology/Toxicology for the FDA, Center for Drug Evaluation & Research 
      • Matt Martin, PhD, Research Biologist, USEPA, Office of Research & Development, National Center for Computational Toxicology  
  • Special Tracks 
    • Toxicology Track 
      • Getting more data from few animals: Innovative strategies for mammalian toxicity testing
        • Lynea Murphy, PhD, Associate Toxicology Manager, Mammalian Toxicology Group Toxicology & Environmental Research and Consulting, The Dow Chemical Company 
      • Cardiac Stem Cells for Safety Pharmacology Application 
        • Kyle Kolaja, Vice President, Business Development, Cellular Dynamics 
      • ToxCast Phase II Data & 3Rs Implications 
        • Matt Martin, PhD, Research Biologist, USEPA, Office of Research & Development, NCCT
    • DMPK Track
      • Microsampling – When less should have been more: One company's experience bridging concept to execution 
        • Alan Stokes, PhD, Interim Head of Toxicology, RTP, GlaxoSmithKline 
      • Development of approaches for efficient and animal-sparing cardiovascular risk assessment in early drug discovery 
        • Charles Thompson, PhD, Merck
      • Optimizing in vivo studies and determination of safe starting dose during drug development: Doing better with less 
        • Arijit Chakravarty, Senior Scientist II, Head of Modeling and Simulation (DMPK) Takeda Pharmaceuticals

 

To register click here and select 2014 3 Rs Sharing Conference 




Upcoming Webinars

UPCOMING WORKSHOPS

Accreditation & Affiliations


The Veterinary Bioscience Institute (VBI)  is an approved continuing education provider by

 


continuing education provider   continuing education provider
VBI’s training meets the following standards:

 

isoglobeguideeuropa

VBI’s courses and workshops also meet the requirements for
Continuing Education Units of 

CE     CE